Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $454.53 | 25 | 93.8% |
| Education | $29.80 | 1 | 6.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $137.25 | 4 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $67.22 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $59.21 | 4 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $54.04 | 3 | $0 (2019) |
| Novo Nordisk Inc | $44.72 | 3 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $21.29 | 1 | $0 (2022) |
| Boston Scientific Corporation | $18.76 | 1 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $16.93 | 1 | $0 (2020) |
| Mylan Specialty L.P. | $16.77 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $13.24 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38.41 | 2 | Bayer Healthcare Pharmaceuticals Inc. ($19.65) |
| 2023 | $66.44 | 4 | Novo Nordisk Inc ($44.72) |
| 2022 | $98.80 | 6 | Bayer HealthCare Pharmaceuticals Inc. ($47.57) |
| 2021 | $28.29 | 2 | Janssen Pharmaceuticals, Inc ($15.05) |
| 2020 | $123.10 | 3 | Janssen Pharmaceuticals, Inc ($95.08) |
| 2019 | $68.11 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($29.80) |
| 2018 | $48.29 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($24.24) |
| 2017 | $12.89 | 1 | AstraZeneca Pharmaceuticals LP ($12.89) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Cardio-renal | ||||||
| 11/30/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Obesity | ||||||
| 10/26/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.79 | General |
| 08/01/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.97 | General |
| 05/11/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.72 | General |
| 10/04/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/21/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/17/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardio-renal | ||||||
| 03/23/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Cardio-renal | ||||||
| 02/28/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: PSYCHIATRY | ||||||
| 02/01/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Cardio-renal | ||||||
| 10/14/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/05/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Respiratory | ||||||
| 06/03/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $16.93 | General |
| Category: Cardiovascular | ||||||
| 03/10/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $95.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/09/2019 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: Diabetes | ||||||
| 10/24/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/28/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Education | In-kind items and services | $29.80 | General |
| Category: RESPIRATORY | ||||||
| 06/11/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Respiratory | ||||||
| 09/10/2018 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $11.91 | General |
| Category: NEUROLOGY | ||||||
| 08/21/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: DIABETES | ||||||
| 01/02/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,160 | 1,730 | $156,427 | $99,787 |
| 2022 | 13 | 1,176 | 1,661 | $163,335 | $101,442 |
| 2021 | 14 | 1,162 | 1,695 | $173,400 | $110,423 |
| 2020 | 12 | 1,156 | 1,731 | $174,285 | $90,891 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 120 | 228 | $44,460 | $27,048 | 60.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 301 | $40,635 | $25,046 | 61.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 179 | 179 | $26,850 | $21,537 | 80.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 174 | $15,660 | $10,111 | 64.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 194 | 371 | $3,710 | $3,116 | 84.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 173 | 173 | $5,190 | $2,946 | 56.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 32 | 32 | $2,720 | $2,302 | 84.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 47 | 55 | $4,125 | $2,293 | 55.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 29 | 32 | $4,800 | $1,742 | 36.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $3,245 | $1,389 | 42.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 30 | 33 | $1,485 | $786.00 | 52.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 32 | 32 | $800.00 | $784.00 | 98.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 13 | $767.00 | $375.12 | 48.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 44 | 84 | $1,260 | $184.81 | 14.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $720.00 | $127.08 | 17.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 166 | 301 | $58,695 | $34,189 | 58.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 202 | 202 | $30,300 | $24,875 | 82.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 275 | $37,125 | $22,038 | 59.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 97 | $8,730 | $5,221 | 59.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 42 | 42 | $3,570 | $2,879 | 80.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 154 | 154 | $4,620 | $2,636 | 57.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $4,720 | $2,442 | 51.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 29 | 36 | $5,400 | $2,364 | 43.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 41 | 48 | $3,600 | $1,998 | 55.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 205 | 377 | $3,770 | $1,116 | 29.6% |
About Dr. Carlene Klassen, MD
Dr. Carlene Klassen, MD is a Specialist healthcare provider based in Wichita, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1356347470.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carlene Klassen, MD has received a total of $484.33 in payments from pharmaceutical and medical device companies, with $38.41 received in 2024. These payments were reported across 26 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($454.53).
As a Medicare-enrolled provider, Klassen has provided services to 4,654 Medicare beneficiaries, totaling 6,817 services with total Medicare billing of $402,544. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Wichita, KS
- Active Since 06/23/2005
- Last Updated 04/04/2024
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1356347470
Products in Payments
- XARELTO (Drug) $137.25
- Kerendia (Drug) $67.22
- SPIRIVA RESPIMAT (Drug) $29.80
- SYMBICORT (Drug) $26.40
- REXULTI (Drug) $21.29
- WATCHMAN FLX (Device) $18.76
- Livalo (Drug) $16.93
- Yupelri (Drug) $16.77
- Wegovy (Drug) $15.96
- BELSOMRA (Drug) $13.24
- TRADJENTA (Drug) $12.58
- Repatha (Biological) $12.14
- NORTHERA (Drug) $11.91
- STIOLTO (Drug) $11.66
- BREZTRI AEROSPHERE (Drug) $11.09
- BASAGLAR (Drug) $10.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Wichita
Eva Henry, M.d, M.D
Specialist — Payments: $92,445
Dr. Dennis Ross, M.d, M.D
Specialist — Payments: $28,748
Dr. Matthew Conrad, M.d, M.D
Specialist — Payments: $25,839
Olga Tatpati, M.d, M.D
Specialist — Payments: $5,719
Dr. Lyle Zepick, M.d, M.D
Specialist — Payments: $4,133
Anna Stork-Fury, D.o, D.O
Specialist — Payments: $3,901